COMPANY
Proteovista
Funding and NIH signals
- NIH award NIH awarded $286K (SBIR Phase I 1R43GM165210-01, new, notice Sep 16, 2026); 2 NIH awards totaling $592K in the last 12 months. NIH RePORTER 1R43GM165210-01 (Sep 16, 2026)
Evidence (2 events)
- Sep 16, 2026 · NIH RePORTER 1R43GM165210-01
Organization: PROTEOVISTA, LLC; City/State: MADISON, WI; Project number: 1R43GM165210-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-16; FY total cost (award amount): 286118; Administering IC: National Institute of General Medical Sciences; Project title: Development of the High-Density SNAP-Dimer Microarray for Functional Analysis of Dimeric Protein Complexes; Organization type: Domestic For-Profits - Jun 5, 2026 · NIH RePORTER 1R43GM163471-01
Organization: PROTEOVISTA, LLC; City/State: MADISON, WI; Project number: 1R43GM163471-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-06-05; FY total cost (award amount): 306151; Administering IC: National Institute of General Medical Sciences; Project title: Development of ClusterBuild to Synthesize Biosynthetic Gene Clusters; Organization type: Domestic For-Profits
- Sep 16, 2026 · NIH RePORTER 1R43GM165210-01
Timeline
- Grant Government grant — SBIR: $286,118 (annual award, as published), announced Sep 16, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
- Grant Government grant — SBIR: $306,151 (annual award, as published), announced Jun 5, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
Funding
- Government grant — SBIR: $286,118 (annual award, as published), announced Sep 16, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
- Government grant — SBIR: $306,151 (annual award, as published), announced Jun 5, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
NIH awards 16
- NIH award 1R43HG012745-01 FY2023: $376,800 awarded for that fiscal year; activity R43 (SBIR); PI WARREN, CHRISTOPHER L; recipient as written: PROTEOVISTA, LLC, MADISON, WI. Development of GenomeBuild as a Universal M source ↗
- NIH award 5R21CA229069-03 FY2022: $110,028 awarded for that fiscal year; activity R21 (OTHER_NIH); PI WARREN, CHRISTOPHER L; recipient as written: PROTEOVISTA, LLC, MADISON, WI. SNAP-X: Development of a Mutagenesis S source ↗
- NIH contract (government contract; not a grant and not an investment round) 75N93021C00055-0-9999-1 FY2021: $600,000 awarded for that fiscal year; activity N43 (OTHER_NIH); PI OZERS, MARY; recipient as written: PROTEOVISTA, LLC, MADISON, WI. DEVELOPMENT OF APT source ↗
- NIH award 3R21CA229069-02S1 FY2020: $129,050 awarded for that fiscal year; activity R21 (OTHER_NIH); PI WARREN, CHRISTOPHER L; recipient as written: PROTEOVISTA, LLC, MADISON, WI. SNAP-X: Development of a Mutagenesis source ↗
- NIH award 5R21CA229069-02 FY2020: $168,410 awarded for that fiscal year; activity R21 (OTHER_NIH); PI WARREN, CHRISTOPHER L; recipient as written: PROTEOVISTA, LLC, MADISON, WI. SNAP-X: Development of a Mutagenesis S source ↗
- NIH award 1R43CA236167-01A1 FY2019: $224,527 awarded for that fiscal year; activity R43 (SBIR); PI WARREN, CHRISTOPHER L; recipient as written: PROTEOVISTA, LLC, MADISON, WI. Development of the High Throughput APT-SN source ↗
- NIH award 1R21CA229069-01A1 FY2019: $168,410 awarded for that fiscal year; activity R21 (OTHER_NIH); PI WARREN, CHRISTOPHER L; recipient as written: PROTEOVISTA, LLC, MADISON, WI. SNAP-X: Development of a Mutagenesis source ↗
- NIH award 1R43CA232913-01 FY2018: $222,678 awarded for that fiscal year; activity R43 (SBIR); PI OZERS, MARY SZATKOWSKI; recipient as written: PROTEOVISTA, LLC, MADISON, WI. Site-Specific Incorporation of Phosphoryla source ↗
- NIH award 5R43HL118893-02 FY2016: $326,050 awarded for that fiscal year; activity R43 (SBIR); PI OZERS, MARY SZATKOWSKI; recipient as written: PROTEOVISTA, LLC, MADISON, WI. Aptamer-Based Detection of Cardiac Biomark source ↗
- NIH award 5R21CA182335-03 FY2015: $107,112 awarded for that fiscal year; activity R21 (OTHER_NIH); PI OZERS, MARY SZATKOWSKI; recipient as written: PROTEOVISTA, LLC, MADISON, WI. High Density Peptide Arrays for Cance source ↗
- NIH award 1R43HL118893-01A1 FY2014: $317,350 awarded for that fiscal year; activity R43 (SBIR); PI OZERS, MARY SZATKOWSKI; recipient as written: PROTEOVISTA, LLC, MADISON, WI. Aptamer-Based Detection of Cardiac Bioma source ↗
- NIH award 5R21CA182335-02 FY2014: $207,796 awarded for that fiscal year; activity R21 (OTHER_NIH); PI OZERS, MARY SZATKOWSKI; recipient as written: PROTEOVISTA, LLC, MADISON, WI. High Density Peptide Arrays for Cance source ↗
- NIH award 1R21CA182335-01 FY2013: $208,123 awarded for that fiscal year; activity R21 (OTHER_NIH); PI OZERS, MARY SZATKOWSKI; recipient as written: PROTEOVISTA, LLC, MADISON, WI. High Density Peptide Arrays for Cance source ↗
- NIH award 5R43CA163405-02 FY2012: $144,658 awarded for that fiscal year; activity R43 (SBIR); PI OZERS, MARY SZATKOWSKI; recipient as written: PROTEOVISTA, LLC, MADISON, WI. High Throughput Method to Assess SNP Funct source ↗
- NIH award 1R43CA163405-01 FY2011: $150,000 awarded for that fiscal year; activity R43 (SBIR); PI WARREN, CHRISTOPHER L; recipient as written: PROTEOVISTA, LLC, MADISON, WI. High Throughput Method to Assess SNP Functi source ↗
- NIH award 1R43CA159655-01A1 FY2011: $218,168 awarded for that fiscal year; activity R43 (SBIR); PI OZERS, MARY SZATKOWSKI; recipient as written: PROTEOVISTA, LLC, MADISON, WI. Screening of FoxA1-ER-DNA disruptors for source ↗